Cargando…

Prediction of clinical outcome in CLL based on recurrent gene mutations, CLL-IPI variables, and (para)clinical data

A highly variable clinical course, immune dysfunction, and a complex genetic blueprint pose challenges for treatment decisions and the management of risk of infection in patients with chronic lymphocytic leukemia (CLL). In recent years, the use of machine learning (ML) technologies has made it possi...

Descripción completa

Detalles Bibliográficos
Autores principales: Parviz, Mehdi, Brieghel, Christian, Agius, Rudi, Niemann, Carsten U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631547/
https://www.ncbi.nlm.nih.gov/pubmed/35468622
http://dx.doi.org/10.1182/bloodadvances.2021006351